Transfer of in vivo primed transgenic T cells supports allergic lung inflammation and FIZZ1 and Ym1 production in an IL-4Rα and STAT6 dependent manner
Open Access
- 20 October 2011
- journal article
- Published by Springer Nature in BMC Immunology
- Vol. 12 (1) , 60
Abstract
Background: CD4+ T helper type 2 (TH2) cells, their cytokines IL-4, IL-5 and IL-13 and the transcription factor STAT6 are known to regulate various features of asthma including lung inflammation, mucus production and airway hyperreactivity and also drive alternative activation of macrophages (AAM). However, the precise roles played by the IL-4/IL-13 receptors and STAT6 in inducing AAM protein expression and modulating specific features of airway inflammation are still unclear. Since TH2 differentiation and activation plays a pivotal role in this disease, we explored the possibility of developing an asthma model in mice using T cells that were differentiatedin vivo.Results: In this study, we monitored the activation and proliferation status of adoptively transferred allergen-specific naïve orin vivoprimed CD4+ T cells. We found that both the naïve andin vivoprimed T cells expressed similar levels of CD44 and IL-4. However,in vivoprimed T cells underwent reduced proliferation in a lymphopenic environment when compared to naïve T cells. We then used thesein vivogenerated effector T cells in an asthma model. Although there was reduced inflammation in mice lacking IL-4Rα or STAT6, significant amounts of eosinophils were still present in the BAL and lung tissue. Moreover, specific AAM proteins YM1 and FIZZ1 were expressed by epithelial cells, while macrophages expressed only YM1 in RAG2-/-mice. We further show that FIZZ1 and YM1 protein expression in the lung was completely dependent on signaling through the IL-4Rα and STAT6. Consistent with the enhanced inflammation and AAM protein expression, there was a significant increase in collagen deposition and smooth muscle thickening in RAG2-/-mice compared to mice deficient in IL-4Rα or STAT6.Conclusions: These results establish that transfer ofin vivoprimed CD4+ T cells can induce allergic lung inflammation. Furthermore, while IL-4/IL-13 signaling through IL-4Rα and STAT6 is essential for AAM protein expression, lung inflammation and eosinophilia are only partially dependent on this pathway. Further studies are required to identify other proteins and signaling pathways involved in airway inflammation.Keywords
This publication has 73 references indexed in Scilit:
- STAT6 Expression in Multiple Cell Types Mediates the Cooperative Development of Allergic Airway DiseaseThe Journal of Immunology, 2011
- How are TH2-type immune responses initiated and amplified?Nature Reviews Immunology, 2010
- Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthmaJournal of Experimental Medicine, 2009
- Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosisJournal of Experimental Medicine, 2009
- Retnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type ImmunityPLOS Pathogens, 2009
- Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in MacrophagesScience Signaling, 2008
- CD4 T cells: fates, functions, and faultsBlood, 2008
- Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesisProceedings of the National Academy of Sciences, 2008
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene familyThe EMBO Journal, 2000